SARS-COV-2 HB02 STRAIN .BETA.-PROPIOLACTONE INACTIVATED VACCINE ANTIGEN
UNII JF2MW5F59G

Substance Identification & Data

This profile provides standardized clinical and technical data for Sars-cov-2 Hb02 Strain .beta.-propiolactone Inactivated Vaccine Antigen, uniquely identified by the FDA Unique Ingredient Identifier (UNII) JF2MW5F59G.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number N/A and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
JF2MW5F59G
CAS Registry Number
N/A
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
SARS-COV-2 HB02 STRAIN .BETA.-PROPIOLACTONE INACTIVATED VACCINE ANTIGEN
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
National Cancer Institute reference terminology for clinical and research data.
Substance Type
structurallyDiverse
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Sars-cov-2 Hb02 Strain .beta.-propiolactone Inactivated Vaccine Antigen. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Common Names & Synonyms

SARS-COV-2 HB02 STRAIN .BETA.-PROPIOLACTONE INACTIVATED VACCINE ANTIGEN
SINOPHARM'S SARS-COV-2 BEIJING VACCINE (HB02 STRAIN) ANTIGEN

Technical Codes

BBIBP-CORV VACCINE ANTIGEN